105 related articles for article (PubMed ID: 22372557)
1. In vitro 2-deoxy-2-[18F]fluoro-D-glucose uptake: practical considerations.
Mertens K; Mees G; Lambert B; Van de Wiele C; Goethals I
Cancer Biother Radiopharm; 2012 Apr; 27(3):183-8. PubMed ID: 22372557
[TBL] [Abstract][Full Text] [Related]
2. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
Ong LC; Jin Y; Song IC; Yu S; Zhang K; Chow PK
Acta Radiol; 2008 Dec; 49(10):1145-53. PubMed ID: 18979289
[TBL] [Abstract][Full Text] [Related]
3. Glucose metabolism gene expression patterns and tumor uptake of ¹⁸F-fluorodeoxyglucose after radiation treatment.
Wilson GD; Thibodeau BJ; Fortier LE; Pruetz BL; Galoforo S; Baschnagel AM; Chunta J; Oliver Wong CY; Yan D; Marples B; Huang J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):620-7. PubMed ID: 25304950
[TBL] [Abstract][Full Text] [Related]
4. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
Aloj L; Caracó C; Jagoda E; Eckelman WC; Neumann RD
Cancer Res; 1999 Sep; 59(18):4709-14. PubMed ID: 10493529
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism underlying the detection of colorectal cancer by 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography.
Izuishi K; Yamamoto Y; Sano T; Takebayashi R; Nishiyama Y; Mori H; Masaki T; Morishita A; Suzuki Y
J Gastrointest Surg; 2012 Feb; 16(2):394-400. PubMed ID: 22065316
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.
Paudyal B; Oriuchi N; Paudyal P; Tsushima Y; Higuchi T; Miyakubo M; Ishikita T; Nakajima T; Endo K
Ann Nucl Med; 2008 Jan; 22(1):83-6. PubMed ID: 18250992
[TBL] [Abstract][Full Text] [Related]
7. Biological correlation of ¹⁸F-FDG uptake on PET in pulmonary neuroendocrine tumors.
Kaira K; Murakami H; Endo M; Ohde Y; Naito T; Kondo H; Nakajima T; Yamamoto N; Takahashi T
Anticancer Res; 2013 Oct; 33(10):4219-28. PubMed ID: 24122985
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.
Seo S; Hatano E; Higashi T; Nakajima A; Nakamoto Y; Tada M; Tamaki N; Iwaisako K; Kitamura K; Ikai I; Uemoto S
Int J Oncol; 2009 May; 34(5):1303-12. PubMed ID: 19360342
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of diethylnitrosamine- or hepatitis B virus X gene-induced hepatocellular carcinoma with 18F-FDG PET/CT: a preclinical study.
Park JH; Kang JH; Lee YJ; Kim KI; Lee TS; Kim KM; Park JA; Ko YO; Yu DY; Nahm SS; Jeon TJ; Park YS; Lim SM
Oncol Rep; 2015 Jan; 33(1):347-53. PubMed ID: 25371060
[TBL] [Abstract][Full Text] [Related]
10. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
Nakajo M; Kajiya Y; Tani A; Yoneda S; Shirahama H; Higashi M; Nakajo M
Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
[TBL] [Abstract][Full Text] [Related]
11. Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer.
Kaira K; Serizawa M; Koh Y; Takahashi T; Yamaguchi A; Hanaoka H; Oriuchi N; Endo M; Ohde Y; Nakajima T; Yamamoto N
Lung Cancer; 2014 Feb; 83(2):197-204. PubMed ID: 24365102
[TBL] [Abstract][Full Text] [Related]
12. Regulation of 18F-FDG accumulation in colorectal cancer cells with mutated KRAS.
Iwamoto M; Kawada K; Nakamoto Y; Itatani Y; Inamoto S; Toda K; Kimura H; Sasazuki T; Shirasawa S; Okuyama H; Inoue M; Hasegawa S; Togashi K; Sakai Y
J Nucl Med; 2014 Dec; 55(12):2038-44. PubMed ID: 25453050
[TBL] [Abstract][Full Text] [Related]
13. PET Imaging of Hepatocellular Carcinomas:
Zhao J; Zhang Z; Nie D; Ma H; Yuan G; Su S; Liu S; Liu S; Tang G
Mol Imaging; 2019; 18():1536012118821032. PubMed ID: 30799682
[TBL] [Abstract][Full Text] [Related]
14. Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats.
Menzel MI; Farrell EV; Janich MA; Khegai O; Wiesinger F; Nekolla S; Otto AM; Haase A; Schulte RF; Schwaiger M
J Nucl Med; 2013 Jul; 54(7):1113-9. PubMed ID: 23596002
[TBL] [Abstract][Full Text] [Related]
15. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.
Gu J; Yamamoto H; Fukunaga H; Danno K; Takemasa I; Ikeda M; Tatsumi M; Sekimoto M; Hatazawa J; Nishimura T; Monden M
Dig Dis Sci; 2006 Dec; 51(12):2198-205. PubMed ID: 17080242
[TBL] [Abstract][Full Text] [Related]
16. Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma.
Shim HK; Lee WW; Park SY; Kim H; Kim SE
Oncol Res; 2009; 17(7):331-7. PubMed ID: 19408578
[TBL] [Abstract][Full Text] [Related]
17. High 18F-FDG uptake in PMAH correlated with normal expression of Glut1, HK1, HK2, and HK3.
Cavalcante IP; Zerbini MC; Alencar GA; Mariani Bde P; Buchpiguel CA; Almeida MQ; Mendonca BB; Fragoso MC
Acta Radiol; 2016 Mar; 57(3):370-7. PubMed ID: 25766729
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the roles of glucose transporter 1 and hexokinase 2 in the metabolism of glucose by extrahepatic bile duct cancer cells.
Yoon SO; Jeon TJ; Park JS; Ryu YH; Lee JH; Yoo JS; Kim JK; Yoon DS; Oh EJ
Clin Nucl Med; 2015 Mar; 40(3):e178-82. PubMed ID: 25608150
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo characterization of 2-deoxy-2-18F-fluoro-D-mannose as a tumor-imaging agent for PET.
Furumoto S; Shinbo R; Iwata R; Ishikawa Y; Yanai K; Yoshioka T; Fukuda H
J Nucl Med; 2013 Aug; 54(8):1354-61. PubMed ID: 23843565
[TBL] [Abstract][Full Text] [Related]
20. No relationship between 18F-fluorodeoxyglucose positron emission tomography and expression of Glut-1 and -3 and hexokinase I and II in high-grade glioma.
Charnley N; Airley R; Du Plessis D; West C; Brock C; Barnett C; Matthews J; Symonds K; Bottomly M; Swindell R; Price P
Oncol Rep; 2008 Sep; 20(3):537-42. PubMed ID: 18695903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]